On Friday, Denali Therapeutics Inc (DNLI) stock saw a modest uptick, ending the day at $27.05 which represents a slight increase of $1.09 or 4.20% from the prior close of $25.96. The stock opened at ...

Jefferies raised the firm’s price target on Denali Therapeutics (DNLI) to $45 from $40 and keeps a Buy rating on the shares ahead of the ...

In a report released today, Michael Yee from Jefferies maintained a Buy rating on Denali Therapeutics (DNLI – Research Report), with a ...

Ryan J. Watts, President and CEO of Denali Therapeutics Inc. (NASDAQ:DNLI), recently sold 40,000 shares of the company's common stock. The shares were sold at an average price range of $27.49 to $ ...

Ryan J. Watts, President and CEO of Denali Therapeutics Inc. (NASDAQ:DNLI), recently sold 40,000 shares of the company's common stock. The shares were sold at an average price range of $27.49 to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The pair climbed Denali and sampled microplastics along their route in June, 2024. (Photo by Roger Jaramillo) Two mountaineers who are also University of Alaska Fairbanks students were successful ...

Dr. Carole Ho, chief medical officer at neurological biotech Denali Therapeutics, sat down with Lauren to discuss what’s next for the Rare Disease Innovation Hub and the rare-disease community ...

Related: Up Close With the 2024 GMC Sierra EV Denali Edition 1 There is one major development for the 2025 GMC Sierra EV: The introduction of a new, smaller battery. That this smaller pack is ...